Some lack enough human data to be recommendable, and others just aren't dosed highly enough to matter
HBOT for inflammation and recovery
765 , 290297 (1995) Bullock, R
Cerebrolysin Cerebrolysin is a nootropic peptide that possesses neuroprotective and neurotrophic repair properties
Conservative starting doses would be essential: Initial phase : Cagrilintide 0.3 mg + Tirzepatide 2.5 mg weekly Escalation : Increase cagrilintide by 0.3-0.6 mg every 4 weeks Tirzepatide adjustment : Maintain or modestly increase based on tolerance Monitoring : Close observation for cumulative GI effects This remains speculative, as no published trials have examined this specific combination
investigated the eryptosis rate in healthy RBCs treated with different concentrations of IL-6, IL-1, urea, and p -cresol, comparable to their plasma levels in CKD patients, at different time points, and evaluated the cytotoxic effect on RBCs by an in vitro setting